ACHFF (ACHFF) Stock Price & Analysis
ACHFF (ACHFF) fell 2.83% to USD 0.34 as of June 10, 2026 at 07:26 UTC, according to Nexqual real-time market data.
ACHFF last closed at USD 0.35; the session ranged USD 0.34–0.35 on volume of 12,500 shares. Market capitalization is $23.10M, with a 52-week range of USD 0.29–1.42 (OQB). Source: Nexqual, June 10, 2026 at 07:26 UTC.
Key Statistics (as of June 10, 2026 at 07:26 UTC)
| Price | USD 0.34 |
|---|---|
| Change | ▼ 2.83% (down) |
| Previous Close | USD 0.35 |
| Open | USD 0.35 |
| Day Range | USD 0.34 – 0.35 |
| 52-Week Range | USD 0.29 – 1.42 |
| Volume | 12,500 shares |
| Market Cap | $23.10M |
| Exchange | OQB |
Technical Analysis (ACHFF)
Nexqual's technical model rates ACHFF "BUY" based on 4 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 07:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.25 (neutral) |
| vs SMA50 | Below (USD 0.34) |
| MACD | 0 (positive) |
Analyst Ratings (ACHFF)
Wall Street analysts rate ACHFF "None", per Nexqual as of June 10, 2026 at 07:26 UTC.
| Consensus Rating | None |
|---|
Earnings (ACHFF)
| Next Earnings Date | 2026-08-28 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-06-30 | USD -0.01 vs est -0.02 ▲ beat |
| 2024-03-31 | USD -0.02 vs est -0.02 ▲ beat |
Source: Nexqual, June 10, 2026 at 07:26 UTC.
Financials & Fundamentals (ACHFF)
| Total Revenue | $158,079 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -1418.63% |
| Profit Margin | +0.00% |
| Current Ratio | 0.11 |
| Total Cash | $436,765 |
| Total Debt | $2.73M |
| Free Cash Flow | $-243,782 |
Source: Nexqual, June 10, 2026 at 07:26 UTC.
Financial Health Score (ACHFF)
Nexqual rates ACHFF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:26 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $437K cash vs $3M debt |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Mixed — No data |
Ownership (ACHFF)
| Insider Ownership | +19.17% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 67.93M |
| Float | 52.93M |
Source: Nexqual, June 10, 2026 at 07:26 UTC.
Leadership (ACHFF)
ACHFF is led by Richard Gabriel Muruve (age 54), Co-Founder, CEO, President & Director, per Nexqual as of June 10, 2026 at 07:26 UTC.
| Co-Founder, CEO, President & Director | Richard Gabriel Muruve (age 54) |
|---|---|
| CFO & Director | Andrew Bishop (age 59) |
| Director of Communications & Clinical Data Management | Aaron Benson |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRBCF | Sirona Biochem Corp. | USD 0.01 | ▲ 0% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| KNBIF | Kane Biotech Inc. | USD 0.03 | ▲ 14.68% |
| ACBM | ACRO BIOMEDICAL CO LTD | USD 0.03 | ▲ 0% |
| AVCNF | Avicanna Inc. | USD 0.08 | ▼ 3.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:26 UTC. This page is informational and not investment advice.